Advisortrust Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.77M Buy
1,473
+93
+7% +$95K 0.6% 37
2026
Q1
$1.27M Sell
1,380
-8
-0.6% -$8.11K 0.53% 36
2025
Q4
$1.49M Buy
+1,388
New +$1.33M 0.66% 29

Other funds holding LLY

Advisortrust Partners's LLY Position: Q2 2026 in Review

Advisortrust Partners increased its Eli Lilly (LLY) stake by 6.7% in Q2 2026, buying an estimated $95K and bringing the position to 1,473 shares worth $1.77M. The position accounts for 0.6% of the portfolio, ranked #37.

Advisortrust Partners first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Advisortrust Partners held 1,473 shares of Eli Lilly worth $1.77M as of Q2 2026.
  • Advisortrust Partners bought 93 Eli Lilly shares in Q2 2026, an estimated $95K.
  • Eli Lilly made up 0.6% of Advisortrust Partners's portfolio in Q2 2026, its #37 holding.
  • Advisortrust Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Advisortrust Partners's 13F filing for Q2 2026, filed 10 Aug 2026.